Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: A randomized controlled trial

American Heart Journal

Volumn 155, Issue 6, 2008, Pages 1143-1149

  Adabag, A Selcuk ^a   Ishani, Areef ^a   Koneswaran, Suresh ^a   Johnson, Deborah J ^a   Kelly, Rosemary F ^a   Ward, Herbert B ^a   McFalls, Edward O ^a   Bloomfield, Hanna E ^a   Chandrashekhar, Yellaprada ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DELIRIUM; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; HEART PALPITATION; HEART SURGERY; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

ACETYLCYSTEINE; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; PERIOPERATIVE CARE; TREATMENT OUTCOME;

EID: 44149107123     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.01.013     Document Type: Article

References (41)

1. Rosner M.H., and Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1 (2006) 19-32
2. Loef B.G., Epema A.H., Smilde T.D., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16 (2005) 195-200
3. Thakar C.V., Worley S., Arrigain S., et al. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int 67 (2005) 1112-1119
4. Lassnigg A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15 (2004) 1597-1605
5. Antunes P.E., Prieto D., Ferrão de Oliveira J., et al. Renal dysfunction after myocardial revascularization. Eur J Cardiothorac Surg 25 (2004) 597-604
6. Ostermann M.E., Taube D., Morgan C.J., et al. Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med 26 (2000) 565-571
7. Conlon P.J., Stafford-Smith M., White W.D., et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14 (1999) 1158-1162
8. Mangano C.M., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128 (1998) 194-203
9. Zanardo G., Michielon P., Paccagnella A., et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107 (1994) 1489-1495
10. Andersson L.G., Ekroth R., Bratteby L.E., et al. Acute renal failure after coronary surgery-a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 41 (1993) 237-241
11. Chertow G.M., Levy E.M., Hammermeister K.E., et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 10 (1998) 343-348
12. Metnitz P.G., Krenn C.G., Steltzer H., et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30 (2002) 2051-2058
13. Ferguson Jr. T.B., Hammill B.G., Peterson E.D., et al. Decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg 73 (2002) 480-489
14. Baliga R., Ueda N., Walker P.D., et al. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 29 (1997) 465-477
15. Burns K.E., Chu M.W., Novick R.J., et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 294 (2005) 342-350
16. Tossios P., Bloch W., Huebner A., et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 126 (2003) 1513-1520
17. Sucu N., Cinel I., Unlu A., et al. N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 34 (2004) 237-242
18. Zhu J., Yin R., Shao H., et al. N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model. J Thorac Cardiovasc Surg 133 (2007) 696-703
19. DiMari J., Megyesi J., Udvarhelyi N., et al. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 272 (1997) F292-F298
20. Bagshaw S.M., McAlister F.A., Manns B.J., et al. Acetylcysteine in the prevention of contrast-induced nephropathy. Arch Intern Med 166 (2006) 161-166
21. Isenbarger D.W., Kent S.M., and O'Malley P.G. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 92 (2003) 1454-1458
22. Alonso A., Lau J., Jaber B.L., et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 43 (2004) 1-9
23. Tepel M., van der Giet M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
24. Haase M., Haase-Fielitz A., Bagshaw S.M., et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 35 (2007) 1324-1331
25. El-Hamamsy I., Stevens L.M., Carrier M., et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 133 (2007) 7-12
26. Ristikankare A., Kuitunen T., Kuitunen A., et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 97 (2006) 611-616
27. Adabag A.S., Rector T., Mithani S., et al. Prognostic significance of elevated cardiac troponin I after heart surgery. Ann Thorac Surg 83 (2007) 1744-1750
28. Grover F.L., Hammermeister K.E., Burchfiel C., et al. Initial report of the Veterans Administration preoperative risk assessment study for cardiac surgery. Ann Thorac Surg 50 (1990) 12-28
29. Grover F.L., Johnson R.R., Shroyer A.L., et al. The Veterans Affairs continuous improvement in cardiac surgery study. Ann Thorac Surg 58 (1994) 1845-1851
30. Grover F.L., Johnson R.R., Marshal G., et al. Factors predictive of operative mortality among coronary artery bypass subsets. Ann Thorac Surg 56 (1993) 1296-1306
31. Thakar C.V., Arrigain S., Worley S., et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16 (2005) 162-168
32. Leacche M., Rawn J.D., Mihaljevic T., et al. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol 93 (2004) 353-356
33. Bakker J., Zhang H., Depierreux M., et al. Effects of N-acetylcysteine in endotoxic shock. J Crit Care 9 (1994) 236-243
34. Fischer U.M., Tossios P., and Mehlhorn U. Renal protection by radical scavenging in cardiac surgery patients. Curr Med Res Opin 21 (2005) 1161-1164
35. Borgstrom L., Kagedal B., and Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 31 (1986) 217-222
36. Schwann N.M., Horrow J.C., Strong M.D., et al. Does off-pump coronary artery bypass reduce the incidence of clinically evident renal dysfunction after multivessel myocardial revascularization?. Anesth Analg 99 (2004) 959-964
37. Hix J.K., Thakar C.V., Katz E.M., et al. Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality. Crit Care Med 34 (2006) 2979-2983
38. Eren N., Cakir O., Oruc A., et al. Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion 18 (2003) 345-350
39. Schultz M.J. N-acetylcysteine as a preventive measure for acute renal failure: a plea for more accurate detection of renal function in critically ill patients. Crit Care Med 35 (2007) 1633-1634
40. Dharnidharka V.R., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40 (2002) 221-226
41. Herget-Rosenthal S., Marggraf G., Husing J., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 66 (2004) 1115-1122